Literature DB >> 21574030

Ethnicity differences in plasma apoC-III levels between African American and Caucasian youths.

Ji-Young Lee1, Hye-Ryun Hong, Hyun-Sik Kang.   

Abstract

BACKGROUND: Little is known about the association between apoC-III and lipoprotein-lipids in African American (AA) and Caucasian (CA) youths. The aim of this study was to investigate if plasma apoC-III level is associated with ethnicity differences in atherogenic lipoprotein-lipids between AA and CA youths.
METHODS: A total of 202 youths (mean age 16.1±1.3 y, range 13.8-18.9 y) consisting of 122 AA (boys/girls, 52/70) and 80 CA (boys/girls, 40/40) youths were recruited via flyers sent to local high schools. For AA youths, body mass index (BMI) values were 22.5±5.0 kg/m(2) and 25.0±6.8 kg/m(2) for boys and girls, respectively. For CA youths, BMI values were 22.0±4.8 kg/m(2) and 22.1±5.0 kg/m(2) for boys and girls, respectively. Anthropometric variables were measured using standard procedures. Body fat was measured by dual-energy X-ray absorptiometry. Fasting glucose and insulin, lipoprotein-lipids, and apolipoproteins were measured in fasting plasma samples.
RESULTS: AA youths had significantly lower values in apoC-III (P<0.001), triglyceride (P<0.001), and total cholesterol/high-density lipoprotein cholesterol (P=0.011) and higher values in HDLC (P=0.004), apoE (P=0.016), insulin (P=0.027), and homoeostasis model of assessment insulin resistance (HOMA-IR) (P=0.025) than CA youths. Body composition and insulin resistance parameters were significantly associated with apoC-III levels in CA youths, but not in AA youths. Regression analyses showed that waist circumference and HOMA-IR were significant predictors for apoC-III in CA, not AA, youths.
CONCLUSIONS: The findings of the current study suggest that ethnicity differences in atherogenic lipids between AA and CA youths may be associated with differences in apoC-III and apoE levels.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21574030     DOI: 10.1007/s12519-011-0266-8

Source DB:  PubMed          Journal:  World J Pediatr            Impact factor:   2.764


  28 in total

1.  Race, visceral adipose tissue, plasma lipids, and lipoprotein lipase activity in men and women: the Health, Risk Factors, Exercise Training, and Genetics (HERITAGE) family study.

Authors:  J P Després; C Couillard; J Gagnon; J Bergeron; A S Leon; D C Rao; J S Skinner; J H Wilmore; C Bouchard
Journal:  Arterioscler Thromb Vasc Biol       Date:  2000-08       Impact factor: 8.311

2.  Levels and correlates of LDL and VLDL particle sizes among children: the Bogalusa heart study.

Authors:  D S Freedman; B A Bowman; J D Otvos; S R Srinivasan; G S Berenson
Journal:  Atherosclerosis       Date:  2000-10       Impact factor: 5.162

3.  Increased apolipoprotein C-III levels associated with insulin resistance contribute to dyslipidemia in normoglycemic and diabetic subjects from a triethnic population.

Authors:  Hermes Florez; Armando Mendez; Paul Casanova-Romero; Carmen Larreal-Urdaneta; Sumaya Castillo-Florez; David Lee; Ronald Goldberg
Journal:  Atherosclerosis       Date:  2005-11-18       Impact factor: 5.162

4.  Variation at the lipoprotein lipase and apolipoprotein AI-CIII gene loci are associated with fasting lipid and lipoprotein traits in a population sample from Iceland: interaction between genotype, gender, and smoking status.

Authors:  R E Peacock; A Temple; V Gudnason; M Rosseneu; S E Humphries
Journal:  Genet Epidemiol       Date:  1997       Impact factor: 2.135

5.  Triglycerides, apo C3 and Lp B:C3 and cardiovascular risk in type II diabetes.

Authors:  N Gervaise; M A Garrigue; G Lasfargues; P Lecomte
Journal:  Diabetologia       Date:  2000-06       Impact factor: 10.122

6.  LDL size in African Americans, Hispanics, and non-Hispanic whites : the insulin resistance atherosclerosis study.

Authors:  S M Haffner; R D'Agostino; D Goff; B Howard; A Festa; M F Saad; L Mykkänen
Journal:  Arterioscler Thromb Vasc Biol       Date:  1999-09       Impact factor: 8.311

7.  Lipid and apolipoprotein levels and distribution in patients with hypertriglyceridemia: effect of triglyceride reductions with atorvastatin.

Authors:  N A Le; W Innis-Whitehouse; X Li; R Bakker-Arkema; D Black; W V Brown
Journal:  Metabolism       Date:  2000-02       Impact factor: 8.694

8.  Rapid turnover of apolipoprotein C-III-containing triglyceride-rich lipoproteins contributing to the formation of LDL subfractions.

Authors:  Chunyu Zheng; Christina Khoo; Katsunori Ikewaki; Frank M Sacks
Journal:  J Lipid Res       Date:  2007-02-21       Impact factor: 5.922

9.  Impaired fatty acid metabolism in familial combined hyperlipidemia. A mechanism associating hepatic apolipoprotein B overproduction and insulin resistance.

Authors:  M Castro Cabezas; T W de Bruin; H W de Valk; C C Shoulders; H Jansen; D Willem Erkelens
Journal:  J Clin Invest       Date:  1993-07       Impact factor: 14.808

10.  Transcriptional regulation of the apoC-III gene by insulin in diabetic mice: correlation with changes in plasma triglyceride levels.

Authors:  M Chen; J L Breslow; W Li; T Leff
Journal:  J Lipid Res       Date:  1994-11       Impact factor: 5.922

View more
  2 in total

1.  Association of the S2 allele of the SstI polymorphism in the apoC3 gene with plasma apoCIII interacts with unfavorable lipid profiles to contribute to atherosclerosis in the Li ethnic group in China.

Authors:  Minzeng Sun; Lin Chen; Hui Liu; Lihui Ma; Tiansong Wang; Yueli Liu
Journal:  Lipids Health Dis       Date:  2017-11-21       Impact factor: 3.876

2.  Ethnic differences in ApoC-III concentration and the risk of cardiovascular disease: No evidence for the cardioprotective role of rare/loss of function APOC3 variants in non-Europeans.

Authors:  Madhusmita Rout; Megan Lerner; Piers R Blackett; Marvin D Peyton; Stavros Stavrakis; Evgeny Sidorov; Dharambir K Sanghera
Journal:  Am Heart J Plus       Date:  2022-03-31
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.